Skip to main content
Clinical Trials/NCT02167503
NCT02167503
Unknown
Not Applicable

A Retrospective-prospective Observational Study to Evaluate the Effect of Anti-viral Treatment on the Long-term Outcome in Patients With Chronic Hepatitis B (SEARCH-B Study)

Nanfang Hospital, Southern Medical University14 sites in 1 country10,000 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Hepatitis B
Sponsor
Nanfang Hospital, Southern Medical University
Enrollment
10000
Locations
14
Primary Endpoint
Cumulative rates of hepatocellular carcinoma
Last Updated
11 years ago

Overview

Brief Summary

The study was conducted to evaluate the effect of anti-viral treatment on long-term outcome on patients with chronic hepatitis B.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
May 2020
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged over 30 (inclusive) years of old
  • Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months)
  • For patients with HBsAg positive, patients should be undergoing anti-viral treatment
  • For patients with HBsAg negative, a documented evidence of previous anti-viral treatment should be provided.
  • Life expectancy is more than 1 year
  • Good treatment compliance.

Exclusion Criteria

  • Patients has a history of diagnosis of hepatocellular carcinoma
  • Patients with Child Pugh C
  • Coinfected with HCV, HDV and HIV
  • Suffering from other serious disease
  • Taking part in other clinical trial

Outcomes

Primary Outcomes

Cumulative rates of hepatocellular carcinoma

Time Frame: Year 5

Study Sites (14)

Loading locations...

Similar Trials